Literature DB >> 28630377

Effects of cognitive reserve depend on executive and semantic demands of the task.

R Ryan Darby1,2,3,4, Michael Brickhouse5, David A Wolk6,7,8, Bradford C Dickerson3,4,5,9.   

Abstract

BACKGROUND: Cognitive reserve (CR) is one factor that helps to maintain cognitive function in patients with Alzheimer's disease (AD). Whether the effects of CR depend on the semantic/executive components of the task remains unknown.
METHODS: 470 patients (138 with AD, 332 with mild cognitive impairment (MCI)) were selected from the Alzheimer's Disease Neuroimaging Initiative database. Linear regression models were used to determine the effects of CR (years of education) on cognitive performance after controlling for demographic factors and regional cortical atrophy. First, we assessed memory tasks with low (Auditory Verbal Learning Test (AVLT) discriminability), moderate (AVLT delayed recall) and high (Logical Memory Test (LMT) delayed recall) executive/semantic components. Next, we assessed tasks with lower (digit span forward, Trails A) or higher (digit span backwards, Trails B) executive demands, and lower (figure copying) or higher (naming, semantic fluency) semantic demands.
RESULTS: High CR was significantly associated with performance on the LMT delayed recall, approached significance in the AVLT delayed recall and was not significantly associated with performance on AVLT discriminability. High CR was significantly associated with performance on the Trails B and digit span backwards, mildly associated with Trails A performance and was not associated with performance on digit span forwards. High CR was associated with performance on semantic but not visuospatial tasks. High CR was associated with semantic tasks in patients with both MCI and AD, but was only associated with executive functions in patients with MCI.
CONCLUSION: CR may relate to executive functioning and semantic knowledge, leading to preserved cognitive performance in patients with AD pathology. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Alzheimer’s disease; Cognitive reserve; Mild cognitive impairment; executive functioning; neural compensation

Mesh:

Year:  2017        PMID: 28630377      PMCID: PMC5963955          DOI: 10.1136/jnnp-2017-315719

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  47 in total

1.  Influence of leisure activity on the incidence of Alzheimer's disease.

Authors:  N Scarmeas; G Levy; M X Tang; J Manly; Y Stern
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

2.  Hippocampal volume and retention in Alzheimer's disease.

Authors:  Joel H Kramer; Norbert Schuff; Bruce R Reed; Dan Mungas; An-Tao Du; Howard J Rosen; William J Jagust; Bruce L Miller; Michael W Weiner; Helena C Chui
Journal:  J Int Neuropsychol Soc       Date:  2004-07       Impact factor: 2.892

Review 3.  Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve.

Authors:  Daniel Barulli; Yaakov Stern
Journal:  Trends Cogn Sci       Date:  2013-09-07       Impact factor: 20.229

4.  Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Authors:  David A Wolk; Bradford C Dickerson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

5.  Pragmatics of measuring recognition memory: applications to dementia and amnesia.

Authors:  J G Snodgrass; J Corwin
Journal:  J Exp Psychol Gen       Date:  1988-03

Review 6.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

7.  Cognitive decline and survival in Alzheimer's disease according to education level.

Authors:  A Bruandet; F Richard; S Bombois; C A Maurage; I Masse; P Amouyel; F Pasquier
Journal:  Dement Geriatr Cogn Disord       Date:  2007-11-28       Impact factor: 2.959

8.  Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition.

Authors:  Prashanthi Vemuri; Stephen D Weigand; Scott A Przybelski; David S Knopman; Glenn E Smith; John Q Trojanowski; Leslie M Shaw; Charlie S Decarli; Owen Carmichael; Matt A Bernstein; Paul S Aisen; Michael Weiner; Ronald C Petersen; Clifford R Jack
Journal:  Brain       Date:  2011-04-07       Impact factor: 13.501

9.  Cognition, reserve, and amyloid deposition in normal aging.

Authors:  Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

10.  Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau.

Authors:  Bradford C Dickerson; David A Wolk
Journal:  Front Aging Neurosci       Date:  2013-10-11       Impact factor: 5.750

View more
  4 in total

1.  Network localization of clinical, cognitive, and neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Aaron M Tetreault; Tony Phan; Dana Orlando; Ilwoo Lyu; Hakmook Kang; Bennett Landman; R Ryan Darby
Journal:  Brain       Date:  2020-04-01       Impact factor: 13.501

2.  Semantic memory, but not education or intelligence, moderates cognitive aging: a cross-sectional study.

Authors:  Laiss Bertola; Rafaela T Ávila; Maria Aparecida C Bicalho; Leandro F Malloy-Diniz
Journal:  Braz J Psychiatry       Date:  2019 Nov-Dec       Impact factor: 2.697

3.  Resting-state electroencephalographic correlates of cognitive reserve: Moderating the age-related worsening in cognitive function.

Authors:  Ana Buján; Adriana Sampaio; Diego Pinal
Journal:  Front Aging Neurosci       Date:  2022-09-14       Impact factor: 5.702

4.  What determines cognitive estimation ability? Changing contributions of semantic and executive domains as a function of age.

Authors:  Paul Hoffman; Sarah E MacPherson
Journal:  J Neuropsychol       Date:  2022-05-21       Impact factor: 2.276

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.